(株)リボミックの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4591/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/08/03 | 日証協 | 295,800株 | +0.17% | 14,700株 | -77.73% | 375,674株 | +0.64% | 3,107株 | -88.19% |
| 2018/07/27 | 日証協 | 295,300株 | +4.68% | 66,000株 | +87.5% | 373,267株 | -1.69% | 26,300株 | -3.66% |
| 2018/07/20 | 日証協 | 282,100株 | 0% | 35,200株 | 0% | 379,687株 | 0% | 27,300株 | 0% |
| 2018/07/13 | 日証協 | 270,100株 | -1.85% | 16,200株 | -16.49% | 369,487株 | +2.1% | 20,900株 | +91.74% |
| 2018/07/06 | 日証協 | 275,200株 | -0.29% | 19,400株 | +42.65% | 361,887株 | -4.41% | 10,900株 | +1.87% |
| 2018/06/29 | 日証協 | 276,000株 | +3.99% | 13,600株 | +750% | 378,587株 | +0.64% | 10,700株 | +97.78% |
| 2018/06/22 | 日証協 | 265,400株 | -4.94% | 1,600株 | +100% | 376,187株 | -2.28% | 5,410株 | -9.83% |
| 2018/06/15 | 日証協 | 279,200株 | -5.68% | 800株 | -97.39% | 384,957株 | -0.18% | 6,000株 | -75.1% |
| 2018/06/08 | 日証協 | 296,000株 | +10.94% | 30,600株 | -58.14% | 385,657株 | +5.9% | 24,100株 | -47.42% |
| 2018/06/01 | 日証協 | 266,800株 | +18.95% | 73,103株 | +801.5% | 364,157株 | +6.06% | 45,835株 | +234.56% |
| 2018/05/25 | 日証協 | 224,300株 | -12.04% | 8,109株 | -88.56% | 343,352株 | -4.29% | 13,700株 | +82.67% |
| 2018/05/18 | 日証協 | 255,000株 | -4.74% | 70,906株 | -54.23% | 358,752株 | -6% | 7,500株 | -88.74% |
| 2018/05/11 | 日証協 | 267,700株 | +8.21% | 154,906株 | +245.75% | 381,652株 | +8.04% | 66,600株 | +76.19% |
| 2018/05/02 | 日証協 | 247,400株 | -2.52% | 44,803株 | +77.07% | 353,252株 | +0.57% | 37,800株 | +215% |
| 2018/04/27 | 日証協 | 253,800株 | +3.17% | 25,303株 | +517.15% | 351,252株 | +1.47% | 12,000株 | +21.02% |
| 2018/04/20 | 日証協 | 246,000株 | -2.81% | 4,100株 | -84.05% | 346,152株 | +0.44% | 9,916株 | +209.88% |
| 2018/04/13 | 日証協 | 253,100株 | -6.05% | 25,700株 | -24.63% | 344,636株 | -2.13% | 3,200株 | -83.34% |
| 2018/04/06 | 日証協 | 269,400株 | -7.74% | 34,100株 | +135.17% | 352,136株 | +10.63% | 19,205株 | -40.91% |
| 2018/03/30 | 日証協 | 292,000株 | -6.65% | 14,500株 | -82.14% | 318,301株 | -16.49% | 32,500株 | +1254.17% |
※株式分割は考慮していませんのでご注意ください。
Page Top